Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers

In human immunodeficiency virus (HIV)-infected individuals, the proportion of circulating mononuclear cells (PBMCs) which carry HIV provirus and the number of HIV proviral sequences per infected PBMC have been matters for conjecture. Using a double polymerase chain reaction which allows the detection of single molecules of provirus and a method of quantifying the provirus molecules, we have measured provirus frequencies in infected individuals down to a level of one molecule per 10(6) PBMCs. As a general rule, only a small proportion of PBMCs contain provirus (median value of samples from 12 patients, one per 8,000 cells), and most if not all of the infected cells carry a single provirus molecule. The frequency of provirus-carrying cells correlated positively both with the progression of the disease and with the success with which virus could be isolated from the same patients by cocultivation methods. Of seven asymptomatic (Centers for Disease Control stage II) patients, all but one contained one provirus molecule per 6,000 to 80,000 cells; of five Centers for Disease Control stage IV patients, all but one contained one provirus molecule per 700 to 3,300 cells. When considered in conjunction with estimates of the frequency of PBMCs that express viral RNA, our results suggest that either (i) the majority of provirus-containing cells are monocytes or (ii) most provirus-containing lymphocytes are transcriptionally inactive. We also present nucleotide sequence data derived directly from provirus present in vivo which we show is not marred by the in vitro selection of potential virus variants or by errors introduced by Taq polymerase. We argue from these data that, of the provirus present in infected individuals, the proportion which is defective is not high in the regions sequenced.

[1]  C H Fox,et al.  The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. , 1989, Science.

[2]  L. Ratner,et al.  Specificity of polymerase chain amplification reactions for human immunodeficiency virus type 1 DNA sequences. , 1989, AIDS research and human retroviruses.

[3]  K. A. Fleming,et al.  FALSE-POSITIVE RESULTS AND THE POLYMERASE CHAIN REACTION , 1988, The Lancet.

[4]  J. Sninsky,et al.  DIRECT DETECTION OF HIV RNA EXPRESSION IN SEROPOSITIVE SUBJECTS , 1988, The Lancet.

[5]  T. Kunkel,et al.  Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase. , 1988, Biochemistry.

[6]  G. Shaw,et al.  Extensive variation of human immunodeficiency virus type-1 in vivo , 1988, Nature.

[7]  M. Busch,et al.  Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects , 1988, Journal of medical virology.

[8]  C Y Ou,et al.  DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. , 1988, Science.

[9]  P. Monaghan,et al.  Evolution of the structural proteins of human immunodeficiency virus: selective constraints on nucleotide substitution. , 1988, AIDS research and human retroviruses.

[10]  C. Andrews,et al.  Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalities. , 1987, The Journal of pediatrics.

[11]  D. Richman,et al.  Detecting human immunodeficiency virus RNA in peripheral blood mononuclear cells by nucleic acid hybridization. , 1987, The Journal of infectious diseases.

[12]  H. Kessler,et al.  Correlation of serum HIV antigen and antibody with clinical status in HIV‐I infected patients , 1987, Journal of medical virology.

[13]  B. Autran,et al.  AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.

[14]  J. Albert,et al.  ANTIBODY RESPONSE IN PRIMARY HUMAN IMMUNODEFICIENCY VIRUS INFECTION , 1987, The Lancet.

[15]  K. Mullis,et al.  Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection , 1987, Journal of virology.

[16]  N. Costlow,et al.  A molecular titration assay to measure transcript prevalence levels. , 1987, Methods in enzymology.

[17]  K. Mullis,et al.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. , 1987, Methods in enzymology.

[18]  Y. Laurian,et al.  SEROLOGICAL MARKERS IN EARLY STAGES OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HAEMOPHILIACS , 1986, The Lancet.

[19]  L. Epstein,et al.  EXPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN (HIV-Ag) IN SERUM AND CEREBROSPINAL FLUID DURING ACUTE AND CHRONIC INFECTION , 1986, The Lancet.

[20]  D. Markovitz,et al.  The role of mononuclear phagocytes in HTLV-III/LAV infection. , 1986, Science.

[21]  J. Mcdougal,et al.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). , 1986, Journal of immunology.

[22]  H. Gendelman,et al.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus , 1986, The Journal of experimental medicine.

[23]  R. Redfield,et al.  Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. , 1986, Science.

[24]  Hans Wolf,et al.  Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS , 1986, Cell.

[25]  M. Hirsch,et al.  Infection of monocyte/macrophages by human T lymphotropic virus type III. , 1986, The Journal of clinical investigation.

[26]  R. Cheynier,et al.  Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. , 1986, Science.

[27]  R. Gallo,et al.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Groopman,et al.  Human T lymphotropic virus type III infection of human alveolar macrophages. , 1986, Blood.

[29]  J. Levy,et al.  Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. , 1985, The Journal of infectious diseases.

[30]  J. Hoxie,et al.  Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. , 1985, Science.

[31]  R. Prescott,et al.  HUMAN T-LYMPHOTROPIC VIRUS TYPE III (HTLV-III) INFECTION IN SERONEGATIVE HAEMOPHILIACS AFTER TRANSFUSION OF FACTOR VIII , 1985, The Lancet.

[32]  S. Salahuddin,et al.  Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Shaw,et al.  HTLV-III infection in brains of children and adults with AIDS encephalopathy. , 1985, Science.

[34]  G. Shaw,et al.  Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. , 1984, Science.